Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
The American Journal of Psychiatry
|
April 18, 1998
Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group
G Bondolfi, H Dufour, M Patris, et al.
Journal of Clinical Psychopharmacology
|
June 2, 2001
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers
C B Eap, G Bondolfi, D Zullino, et al.
Therapeutic Drug Monitoring
|
May 22, 2001
Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test
C B Eap, G Bondolfi, D Zullino, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 22, 2009
Self-rated residual symptoms do not predict 1-year recurrence of depression
G Bertschy, E Haffen, N Gervasoni, et al.
Pharmacological Research
|
May 1, 1997
The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine
G Bertschy, C Bryois, G Bondolfi, et al.
Journal of Affective Disorders
|
August 8, 2009
Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice
G Bondolfi, F Jermann, B Weber Rouget, et al.
Neuroscience and Biobehavioral Reviews
|
March 15, 2022
Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?
A Costanza, A Amerio, A Aguglia, et al.
Diabetes & Metabolism
|
November 27, 2018
Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes
J-C Chauvet-Gélinier, A-L Mosca-Boidron, C Lemogne, et al.
The Pharmacogenomics Journal
|
January 22, 2014
Copy number variants and therapeutic response to antidepressant medication in major depressive disorder
K E Tansey, J J H Rucker, D H Kavanagh, et al.
The Pharmacogenomics Journal
|
November 22, 2017
New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation
C Fabbri, K E Tansey, R H Perlis, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
The American Journal of Psychiatry
|
April 18, 1998
Risperidone versus clozapine in treatment-resistant chronic schizophrenia: a randomized double-blind study. The Risperidone Study Group
G Bondolfi, H Dufour, M Patris, et al.
Journal of Clinical Psychopharmacology
|
June 2, 2001
Concentrations of the enantiomers of fluoxetine and norfluoxetine after multiple doses of fluoxetine in cytochrome P4502D6 poor and extensive metabolizers
C B Eap, G Bondolfi, D Zullino, et al.
Therapeutic Drug Monitoring
|
May 22, 2001
Pharmacokinetic drug interaction potential of risperidone with cytochrome p450 isozymes as assessed by the dextromethorphan, the caffeine, and the mephenytoin test
C B Eap, G Bondolfi, D Zullino, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists
|
August 22, 2009
Self-rated residual symptoms do not predict 1-year recurrence of depression
G Bertschy, E Haffen, N Gervasoni, et al.
Pharmacological Research
|
May 1, 1997
The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine
G Bertschy, C Bryois, G Bondolfi, et al.
Journal of Affective Disorders
|
August 8, 2009
Self- and clinician-rated Montgomery-Asberg Depression Rating Scale: evaluation in clinical practice
G Bondolfi, F Jermann, B Weber Rouget, et al.
Neuroscience and Biobehavioral Reviews
|
March 15, 2022
Hyper/neuroinflammation in COVID-19 and suicide etiopathogenesis: Hypothesis for a nefarious collision?
A Costanza, A Amerio, A Aguglia, et al.
Diabetes & Metabolism
|
November 27, 2018
Type A competitiveness traits correlate with downregulation of c-Fos expression in patients with type 1 diabetes
J-C Chauvet-Gélinier, A-L Mosca-Boidron, C Lemogne, et al.
The Pharmacogenomics Journal
|
January 22, 2014
Copy number variants and therapeutic response to antidepressant medication in major depressive disorder
K E Tansey, J J H Rucker, D H Kavanagh, et al.
The Pharmacogenomics Journal
|
November 22, 2017
New insights into the pharmacogenomics of antidepressant response from the GENDEP and STAR*D studies: rare variant analysis and high-density imputation
C Fabbri, K E Tansey, R H Perlis, et al.
Page
of 3